Home › Melanoma › Ohio › Parma
Melanoma clinical trials in Parma, OH
3 studies for Melanoma are looking for participants at sites in and around Parma (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
RecruitingPhase 3
- UH Seidman Cancer Center at UH Avon Health Center, Avon · 17 mi away
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RecruitingPhase 2
- University Hospitals Parma Medical Center, Parma
- UH Seidman Cancer Center at Southwest General Hospital, Middleburg Heights · 6 mi away
- UH Seidman Cancer Center at Saint John Medical Center, Westlake · 11 mi away
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Recruiting
- University Hospitals St. John Medical Center, Westlake · 11 mi away
- University Hospitals Avon Health Center, Avon · 17 mi away
About Melanoma
Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.
More about Melanoma on MedlinePlus
Melanoma trials in other cities
- Houston, TX59 studies
- New York City, NY38 studies
- Los Angeles, CA34 studies
- Nashville, TN33 studies
- Pittsburgh, PA31 studies
- Boston, MA26 studies
- Philadelphia, PA23 studies
- San Francisco, CA22 studies
- Durham, NC21 studies
- Atlanta, GA21 studies
- St. Louis, MO21 studies
- Salt Lake City, UT21 studies
Other studies in Parma
- Ulcerative Colitis10 studies
- Crohn's Disease8 studies
- Steatotic Liver Disease7 studies
- Psoriatic Arthritis6 studies
- Lung Cancer5 studies
- Major Depressive Disorder5 studies
- Schizophrenia5 studies
- Endometrial Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
- Ovarian Cancer4 studies
- Inflammatory Bowel Disease4 studies
- Alzheimer's Disease4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.